InsightRX
InsightRX is a precision medicine company offering an AI-powered Bayesian dosing platform for hospitals and life sciences organizations, serving 1,000+ healthcare facilities with model-informed precision dosing, real-time analytics, and a patented continuous learning system.
- Company typePrivate
- Founded2015
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What InsightRX does
InsightRX is a San Francisco-based precision medicine company founded in 2015 by three pharmacometricians to bring model-informed precision dosing (MIPD) into clinical practice. The company operates an AI-powered platform combining Bayesian pharmacokinetic models, population-level analytics, and machine learning to optimize drug dosing at the point of care and in clinical trials. Its core products include InsightRX Nova, a bedside clinical decision support application for Bayesian dosing; InsightRX Apollo, a real-time clinical analytics platform with a natural-language interface (Apollo Studio); InsightRX Gemini, an automated vancomycin PK model selection algorithm; and Astra, a conversational PK/PD analysis tool for life sciences. A patented Continuous Learning process retrains dosing models using real-world institutional data, creating a data flywheel across 1,000+ hospital deployments and 5.6M+ personalized doses.
The company serves two primary customer segments: healthcare providers (hospital systems and clinical pharmacy teams) requiring precision dosing for therapeutic drug monitoring and antimicrobial stewardship, and life sciences organizations (biopharma and CROs) seeking dose optimization for clinical trials and regulatory submissions including FDA Project Optimus compliance. Go-to-market is sales-led and enterprise-oriented, with direct field sales targeting large hospital systems, multi-year subscription contracts priced based on hospital size and modules deployed, and pharmacist-led implementation and training services. Revenue is generated through annual subscriptions for the platform plus professional services for onboarding. Geographic reach spans the United States and the European Union (via CE Mark certification received in 2020). Customer evidence includes deployments at CHRISTUS Health, Memorial Sloan Kettering, OSF HealthCare, EvergreenHealth, and Cape Cod Healthcare, with documented outcomes such as 70% reduction in AKI events at CHRISTUS and a 96.1 KLAS customer satisfaction rating.
The company is venture-backed and private, having raised approximately $12.8M in equity (seed in 2017, $10M Series A in 2019) plus growth debt from CIBC Innovation Banking in February 2024. It operates with 11-50 employees and maintains an open-source portfolio of R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) supporting the clinical pharmacology research community.
InsightRX firmographics
Firmographics- Name
- InsightRX
- Legal name
- Insight Rx, Inc.
- Website
- https://insight-rx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InsightRX is a precision medicine company offering an AI-powered Bayesian dosing platform for hospitals and life sciences organizations, serving 1,000+ healthcare facilities with model-informed precision dosing, real-time analytics, and a patented continuous learning system.
- Ownership category
- akta.pro rank
InsightRX industry classification
Industry- Product category
- Precision Medicine Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)
- akta.pro secondary industries
- Medication Analytics, Outcomes & Cost Optimization (HLACAKAL), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)
Keywords
Where InsightRX is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
InsightRX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Software Platform Subscription: Annual or multi-year subscription licensing for access to InsightRX Nova, Apollo, and related platform capabilities. Pricing based on hospital size, number of beds, or clinician count. Includes software updates, technical support, and access to drug modules.
- Implementation and Training Services: Pharmacist-led training, onboarding, and education services to help healthcare organizations implement and optimize use of the platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pricing - Quote-based for large hospital systems |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
InsightRX product offering
Product offeringCore offering
InsightRX sells an AI-powered precision medicine software platform that uses Bayesian model-informed precision dosing (MIPD), pharmacokinetic models, real-world data, and machine learning to individualize drug dosing at the point of care for hospitals and in clinical trials for life sciences companies. The platform combines bedside clinical decision support (Nova), real-time population analytics (Apollo), natural-language analytics (Apollo Studio), automated model selection (Gemini), and conversational PK/PD workflow automation (Astra), supported by deep EHR integration and a patented Continuous Learning process.
Product overview
InsightRX offers a comprehensive AI-powered precision medicine platform combining Bayesian model-informed precision dosing (MIPD) with real-time clinical analytics. The core platform consists of InsightRX Nova (bedside clinical decision support for Bayesian dosing) and InsightRX Apollo (real-time pharmacy analytics), supported by Drug Modules for medication coverage and Continuous Learning for model optimization. For life sciences, the company provides Nova for Life Sciences and Apollo for Life Sciences for clinical trial applications, along with Companion Applications. The platform is enhanced by Apollo Studio (natural language analytics), Gemini (automated model selection), and Astra (conversational PK/PD analysis). The company also maintains a suite of open-source R packages (clinPK, PKPDsim, PKPDmap, MIPDtrial, MIPDeval, PKPDposterior) for the clinical pharmacology research community.
Differentiator
Problem solved
Functional benefit
Brands
- Nova: Bayesian dosing (MIPD) app for bedside clinical decision support
- Apollo
- Apollo Studio
- Gemini
- Astra
- Apollo Gold
- Continuous Learning
Products and services
- InsightRX Nova Bayesian dosing (MIPD) application for bedside clinical decision support, enabling pharmacists to individualize drug dosing using patient-specific data and validated population pharmacokinetic models.
- InsightRX Apollo Real-time clinical analytics platform providing population-level reporting, medication use evaluations, and performance tracking for pharmacy program directors.
- InsightRX Gemini Automated vancomycin PK model selection algorithm built on more than 300,000 treatment courses, helping pharmacists select the most appropriate pharmacokinetic model for individual patients.
- Apollo Studio Natural language analytics interface within the Apollo platform that enables pharmacy teams to generate real-time clinical analyses and visualizations from institutional data by describing analyses in plain language.
- Astra Conversational PK/PD analysis and end-to-end workflow automation tool for life sciences researchers, scientists, and pharmacometricians.
- MIPD for Life Sciences MIPD solution for biopharma and clinical trial use, incorporating precision dosing into clinical trials to identify optimal dosing strategies.
- Nova for Life Sciences Precision dosing application for clinical trial use, enabling individualized dosing in research and drug development settings.
- Apollo for Life Sciences Advanced PKPD analytics platform for clinical trials, supporting pharmacometric analysis during drug development.
- Companion Applications Tailored applications used alongside specific medications in life sciences and clinical trial settings.
Quantifiable outcome
- 70% reduction in AKI events, saving $8.1M annually (CHRISTUS Health)
- +8 more outcomes
Companies that use InsightRX
Customer profileNamed customers10 records
Segments2 records
Ideal customer profiles2 records
InsightRX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature8 records
InsightRX partnerships and signals
Strategic signalScale indicators11 records
Recent moves6 records
Expansion highlights6 records
InsightRX competitors and assessment
Company assessmentBroad incumbents
- Tabula Rasa HealthCare (CareVention): Tabula Rasa HealthCare offers medication risk mitigation and pharmacy services including precision dosing tools for at-risk populations. It is a broader incumbent in medication optimization, overlapping with InsightRX on dose individualization but serving PACE/senior care as well as hospital pharmacy.
- Oracle Health (Cerner): Oracle Health (formerly Cerner) is a leading hospital EHR whose PowerChart and pharmacy modules include clinical decision support and dosing tools. Comparable as both an integration partner for InsightRX and an incumbent competitor for pharmacy IT spend in large health systems.
- First Databank (FDB): FDB is a major drug knowledge and clinical decision support vendor whose MedKnowledge and order-entry screening products are embedded in EHRs nationwide. It is comparable as a medication analytics and decision support incumbent that competes for clinical pharmacy IT budget alongside InsightRX Apollo/Nova.
- Epic Systems: Epic is the dominant hospital EHR and embeds clinical decision support, dosing calculators, and Best Care Advisories within its workflow. Comparable as the underlying platform InsightRX integrates with and a potential long-term competitive threat if Epic extends in-house precision dosing capability.
- Wolters Kluwer Clinical Drug Information (Sentri7, Medi-Span): Wolters Kluwer offers Sentri7 pharmacy surveillance and Medi-Span drug data, widely deployed in hospital systems for medication analytics and antimicrobial stewardship. Comparable as a broader incumbent selling into the same pharmacy director and antimicrobial stewardship buyers that InsightRX targets.
Emerging players
- Mendel.ai: Mendel builds AI clinical reasoning and patient-matching tools for life sciences and provider organizations. Comparable as an emerging AI/clinical-informatics player overlapping with InsightRX's biopharma Astra product for clinical development decision support.
- AiCure: AiCure applies AI to medication adherence and clinical trial patient monitoring. Comparable as an adjacent AI-driven medication outcomes player that intersects with InsightRX's clinical-trial dosing and adherence themes but focuses on visual adherence rather than pharmacokinetic modeling.
- Tempus Labs: Tempus is a precision medicine company building AI-driven clinical and molecular data products for oncology and other specialties. Comparable as an adjacent emerging player in precision medicine/AI that intersects with InsightRX's life sciences Astra product for clinical trial dose optimization.
Direct peers
- DoseMeRx (Iguana Solutions): DoseMeRx is a Bayesian model-informed precision dosing (MIPD) platform used by hospitals to individualize drug dosing. It is the closest direct competitor to InsightRX Nova in the bedside Bayesian dosing category, targeting the same pharmacy and antimicrobial stewardship buyers with comparable clinical decision support workflows.
- PrecisePK: PrecisePK provides pharmacokinetic dosing software for hospitals and clinics to optimize drug levels for antibiotics, anticoagulants, and other therapeutic areas. It competes head-on with InsightRX Nova in the AUC-guided vancomycin and aminoglycoside dosing space used by hospital pharmacy teams.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
InsightRX social profiles
Digital presenceInsightRX compliance and trust
Trust signalCompliance1 record
InsightRX financial estimates
Financial estimateRevenue estimate
Valuation estimate
InsightRX leadership team
Management profileNumber of profiles
Profiles7 records
InsightRX funding detail
Funding detailFunding overview
Funding rounds4 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InsightRX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InsightRX
What does InsightRX do?
InsightRX sells an AI-powered precision medicine software platform that uses Bayesian model-informed precision dosing (MIPD), pharmacokinetic models, real-world data, and machine learning to individualize drug dosing at the point of care for hospitals and in clinical trials for life sciences companies. The platform combines bedside clinical decision support (Nova), real-time population analytics (Apollo), natural-language analytics (Apollo Studio), automated model selection (Gemini), and conversational PK/PD workflow automation (Astra), supported by deep EHR integration and a patented Continuous Learning process.
Is InsightRX a public or private company?
InsightRX is a private company. It is classified as venture growth investor backed and is currently operating.
When was InsightRX founded?
InsightRX was founded in 2015. It employs 11 to 50 people.
Where is InsightRX based?
InsightRX is headquartered in San Francisco, United States, in the North America region.
How does InsightRX make money?
Two revenue lines are on record. Software Platform Subscription is the primary driver. The others are implementation and Training Services.
Who are InsightRX's main competitors?
Broad incumbents on record are Tabula Rasa HealthCare (CareVention), Oracle Health (Cerner), First Databank (FDB), Epic Systems and Wolters Kluwer Clinical Drug Information (Sentri7, Medi-Span). Emerging players are Mendel.ai, AiCure and Tempus Labs. Direct peers are DoseMeRx (Iguana Solutions) and PrecisePK.
Does InsightRX have an API?
No public API is recorded for InsightRX.
What industry is InsightRX in?
InsightRX's product category is Precision Medicine Software. Its primary akta.pro industry code is HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems), with a secondary code of HLACAKAL, Medication Analytics, Outcomes & Cost Optimization. Its NAICS code is 5132 and its SIC code is 7372.